866-997-4948(US-Canada Toll Free)

Published on : Jan 25, 2016

The global deep brain stimulation devices market for Parkinson’s disease is projected to expand significantly in the coming few years. Several factors are shaping the growth of the global deep brain stimulation devices market for Parkinson’s disease. Let us look at the top 10 factors that are expected to have a significant impact on this market.

  1. Rising Aging Population: The global deep brain stimulation devices market for Parkinson’s disease is driven by the rapidly rising geriatric population. This trend has led to an elevated risk and high incidence of neurological conditions such as dementia, Parkinson’s disease, and Alzheimer’s disease.
  2. Favorable Reimbursements: Favorable reimbursement framework will also add to the growing acceptance of deep brain stimulation devices around the world. This is one of the key factors that will fuel the overall deep brain stimulation devices market for Parkinson’s disease.
  3. Technological Advancement: The increasing availability of technologically innovative deep brain stimulation (DBS) devices is also projected to have a positive impact on the global deep brain stimulation devices market for Parkinson’s disease.
  4. Emerging Economies: Players in the global deep brain stimulation devices market for Parkinson’s disease will greatly benefit from the high unmet needs of the patient population in the developing economies of the world.
  5. Reduction in Prices: Companies in the global deep brain stimulation devices market for Parkinson’s disease are projected to improve product life and reduce prices of these devices in the coming few years, which will positively impact the global market.
  6. Outsourcing: Another key trend that is expected to benefit companies is the rising trend of outsourcing manufacturing to CMOs.
  7. Rising Public Awareness: The rising awareness of public regarding this disease and its treatment options will also benefit the global deep brain stimulation devices market for Parkinson’s disease in the coming few years.
  8. Demand for MIS: Increasing demand for minimally invasive treatments such as involving deep brain stimulation devices will also propel the global deep brain stimulation devices market for Parkinson’s disease.
  9. Policies: Implementation of specific government policies including the Affordable Care Act is projected to negatively impact the deep brain stimulation devices market in the U.S, which will hamper the overall global market.
  10. Associated Risks: The risks related to deep brain stimulation procedures is expected to suppress the growth of the global deep brain stimulation devices market for Parkinson’s disease.

The global deep brain stimulation devices market for Parkinson’s disease is dominated by a handful of companies. These include Medtronic, Boston Scientific, St. Jude Medical, and Aleva Neurotherapeutics.